Analysis of Yearly Variations in Drug Expenditure for One Patient Using Data Warehouse in a Hospital
暂无分享,去创建一个
Yufeng Chen | Katsuhiko Nakagawa | Yasushi Matsumura | Hiroshi Takeda | Qiyan Zhang | Hirohiko Nakano | Takahiro Mineno | Shanmei Ji | Tadamasa Teratani | T. Teratani | H. Takeda | Y. Matsumura | H. Nakano | Shanmei Ji | Yufeng Chen | Qiyan Zhang | T. Mineno | K. Nakagawa | Tadamasa Teratani
[1] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[2] A. Chawla,et al. Explaining drug spending trends: does perception match reality? , 2000, Health affairs.
[3] L Ruilope. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist. , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[4] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[5] Nilay D Shah,et al. Projecting future drug expenditures--2003. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[6] M Ishii,et al. [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.
[7] Lippincott Williams Wilkins,et al. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.
[8] F M Haaijer-Ruskamp,et al. The cost of prescription medicines to patients. , 2000, Health policy.
[9] G. Anderson,et al. Population aging: a comparison among industrialized countries. , 2000, Health affairs.
[10] G. Anderson,et al. Health spending, access, and outcomes: trends in industrialized countries. , 1999, Health affairs.
[11] Tetsuro Chino,et al. The present and future National Medical Expenditure in Japan (in Japanese) , 1997 .
[12] V MONALDI,et al. [Labor and welfare]. , 1951, Archivio di tisiologia e delle malattie dell'apparato respiratorio.